Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
Microbot Medical signed a three-year exclusive distribution agreement with Medtechnica Ltd. to market and sell the LIBERTY Endovascular Robotic System throughout Israel. The agreement follows Israeli Ministry of Health AMAR regulatory approval and registry listing in May 2026, with initial orders anticipated in Q4 2026.
Key figures
- Agreement term years
- 3
- Initial orders timing
- Q4 2026
- Israel regulatory approval date
- May 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.